TLDR Mothers with alopecia areata have a higher risk of adverse birth outcomes.
This nationwide population-based study in Korea examined 45,328 children born to mothers with alopecia areata (AA) and 4,703,253 controls to assess the impact of maternal AA on birth outcomes. The study found that infants born to mothers with AA had a significantly higher risk of preterm birth, low birthweight, and Caesarean section birth compared to controls. Additionally, there was an increased risk of congenital malformations, particularly affecting the urinary and musculoskeletal systems, in infants born to mothers with AA. The findings suggest that maternal AA is associated with an increased risk of adverse birth outcomes.
57 citations,
April 2019 in “British journal of dermatology/British journal of dermatology, Supplement” Alopecia areata involves immune system imbalances that may lead to depression and anxiety.
191 citations,
May 2018 in “British journal of dermatology/British journal of dermatology, Supplement” Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.
12 citations,
March 2016 in “BBA clinical” Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.
40 citations,
October 2012 in “Dermatologic clinics” More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.
391 citations,
January 2010 in “Journal of The American Academy of Dermatology” Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.
October 2023 in “Acta dermato-venereologica (Print)” People with severe hair loss have lower zinc levels in their blood.